Christine Zhou

Courtesy of Novo Nordisk
  • Title
    Senior Vice President and President of Region China
  • Company/Affiliation
    Novo Nordisk
  • Country/Territory
    China

Christine Zhou started her career as a physician and clocked nearly two decades at drugmaker Eli Lilly before joining rival Novo Nordisk in 2018, where she is now president for the China region. China is a key growth market for the Danish pharma titan, bringing in $2.4 billion in sales in fiscal 2023. Novo said it's investing about $560 million to expand its production facility in Tianjin, and is working to launch blockbuster weight-loss injectable Wegovy in the mainland.